• CAFs Drive Chemoresistance in Prostate Cancer via ANGPTL4-IQ

  2026-04-22

  This study identifies a novel mechanism by which cancer-associated fibroblasts (CAFs) promote chemoresistance in prostate cancer through paracrine ANGPTL4 signaling and mitochondrial metabolic reprogramming. Targeting the ANGPTL4-IQGAP1 pathway offers new therapeutic avenues to improve chemotherapy efficacy.

• In Vitro Drug Response Evaluation in Cancer: Insights and To

  2026-04-21

  Schwartz's dissertation introduces refined in vitro methods to differentiate between proliferative arrest and cell death in anti-cancer drug response studies. This work clarifies how measuring both relative and fractional viability improves the mechanistic understanding of drug action, guiding better experimental design in cancer pharmacology.

• Applied Workflows with EZ Cap™ Cy5 EGFP mRNA (5-moUTP)

  2026-04-21

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) enables simultaneous tracking of mRNA delivery and translation efficiency, streamlining nanoparticle validation and gene regulation studies. Its dual fluorescence and immune-evasive modifications offer actionable advantages for advanced mRNA workflows and troubleshooting.

• Chloroquine: Applied Protocols and Innovations in Autophagy

  2026-04-20

  Chloroquine, a well-characterized autophagy inhibitor, empowers researchers with precise control over lysosomal pH and immune signaling pathways. This article delivers actionable protocols, troubleshooting insights, and highlights from recent mechanistic advances, ensuring optimal assay performance in cancer, malaria, and autoimmune disease models.

• Cyanine 5-dCTP: Enhancing Fluorescent DNA Probe Synthesis

  2026-04-20

  Cyanine 5-dCTP redefines fluorescent DNA labeling with high signal clarity and seamless integration into advanced enzymatic workflows. Backed by recent breakthroughs in DNA framework interfaces, this APExBIO reagent empowers researchers to achieve superior yield, accuracy, and reproducibility in nucleic acid detection and imaging.

• In Vitro Activity of Sisomicin vs. Other Aminoglycosides: Co

  2026-04-19

  This article examines the landmark study evaluating the in vitro efficacy of sisomicin, an aminoglycoside antibiotic, against a wide array of clinical bacterial isolates. The findings offer critical insight into antibiotic resistance patterns and provide context for the continued use and benchmarking of water-soluble aminoglycoside antibiotics such as Kanamycin Sulfate in microbiology research.

• Lysis Buffer as a Rapid Genotyping Kit Component for Mice

  2026-04-18

  Unlock high-integrity genomic DNA extraction from mouse tail tissues with APExBIO's lysis buffer, a cornerstone of rapid genotyping workflows. This guide translates optimized protocols and troubleshooting strategies into practical research wins, connecting innovations in buffer chemistry to real-world genetic analysis success.

• CCR7–Notch1 Crosstalk Drives Stemness in MMTV-PyMT Breast Ca

  2026-04-17

  Boyle et al. revealed a mechanistic intersection between the chemokine receptor CCR7 and Notch1 signaling pathways in mammary cancer stem-like cells. Their findings elucidate how this crosstalk sustains tumor cell stemness and highlight dual-axis targeting as a potential therapeutic strategy to combat breast cancer recurrence.

• Patient-Derived Gastric Cancer Assembloids Advance Drug Test

  2026-04-16

  This study introduces patient-derived gastric cancer assembloid models that integrate matched tumor organoids with stromal subpopulations, providing a physiologically relevant platform to study tumor–microenvironment interactions. The approach enhances the accuracy of drug response assessment and supports the development of personalized therapeutic strategies.

• Brefeldin A: Unlocking ER Stress and Cancer Apoptosis Assays

  2026-04-15

  Brefeldin A (BFA) is a gold-standard ER stress inducer and vesicle transport inhibitor, empowering researchers to dissect protein trafficking and apoptosis in cancer and endothelial models. This guide translates recent breakthroughs and hands-on troubleshooting into actionable protocols with APExBIO's trusted reagent.

• In Vivo CRISPR Screens Reveal GRA12 as a Broad Toxoplasma Vi

  2026-04-14

  This study systematically applies in vivo CRISPR screening to the Toxoplasma gondii secretome, identifying GRA12 as a conserved virulence factor essential for parasite survival across strains and host subspecies. The findings expand understanding of parasite immune evasion and highlight potential strategies for targeting conserved effectors in host-pathogen interactions.

• MHY1485: Strategic mTOR Activation for Translational Researc

  2026-04-13

  This thought-leadership article explores MHY1485, a potent mTOR activator, as a precision tool enabling advanced mechanistic studies and translational workflows. Integrating new evidence from uveal melanoma research, it provides actionable experimental guidance, critical protocol parameters, and strategic recommendations for harnessing mTOR pathway modulation and autophagy inhibition in oncology and reproductive biology.

• Dynamic Remodeling of Damaged Myelin in the CNS: New Insight

  2026-04-13

  Arafa et al. reveal that myelin sheaths in the central nervous system are not passively lost after damage, but can dynamically remodel and recover, challenging longstanding assumptions about demyelination. Their work identifies myelin swelling as an early, reversible feature, linking neuronal activity to the progression of myelin pathology and opening new avenues for therapeutic intervention.

• SGI-1027: DNA Methyltransferase Inhibitor for Cancer Epigene

  2026-04-12

  SGI-1027 stands out as a potent and selective DNA methyltransferase inhibitor, enabling robust gene reactivation and precise epigenetic modulation in cancer research. Its validated workflow integration and reproducibility make it a top choice for scientists targeting DNA methylation pathways and tumor suppressor gene regulation.

• Gallein: G Protein βγ Subunit Inhibitor for Translational Mo

  2026-04-12

  Gallein, a precision G protein βγ subunit inhibitor from APExBIO, empowers researchers to dissect GPCR signaling in cancer, immunity, and cardiometabolic disease. Discover actionable workflows, comparative advantages, and troubleshooting strategies that maximize data clarity and reproducibility in complex experimental systems.

343 records 7/23 page Previous Next First page 上5页 678910 下5页 Last page